Structure Therapeutics (GPCR) Cash Flow: Operating & Free Cash Flow

Structure Therapeutics Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Structure Therapeutics Inc. (GPCR) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Operating Activities
Net Income	-141.20	-122.53	-89.62	-51.32	-38.05	-15.88
Depreciation & Amortization	1.33	0.99	0.30	0.28	0.07	0.00
Stock Based Compensation	28.99	18.79	8.19	2.51	1.49	0.57
Change in Working Capital	-88.04	2.96	6.97	2.97	4.06	0.95
Change in Accounts Payable	4.77	3.31	-0.86	2.15	1.90	1.02
Change in Other Working Capital	-114.32	-8.06	-4.34	0.35	-1.25	-0.88
Other Operating Activities	-23.28	-16.86	-5.32	0.35	0.27	0.08
Net Cash from Operating Activities	-222.20	-116.64	-79.49	-46.12	-32.16	-14.28
Investing Activities
Capital Expenditures	-3.61	-1.29	-2.17	-0.16	-1.21	-0.02
Purchases of Investments	83.16	-357.62	-266.18	-123.45	19.07	-21.13
Sales/Maturities of Investments	630.54	344.90	151.18	61.50	23.28	0.00
Other Investing Activities	10.25	0.00	-0.23	0.00	0.00	0.00
Net Cash from Investing Activities	89.80	-358.91	-268.34	-62.11	17.86	-21.15
Financing Activities
Common Stock Issued	765.15	517.06	473.10	0.00	0.01	0.00
Common Stock Repurchased	-0.62	0.00	0.00	0.00	0.00	0.00
Other Financing Activities	-2.02	-1.80	-21.57	-2.52	3.24	-0.16
Net Cash from Financing Activities	762.52	515.26	451.53	29.01	103.25	25.84
Summary
Effect of Forex Changes on Cash	-1.66	0.00	0.00	0.00	0.00	0.00
Net Change in Cash	630.11	39.72	103.70	-79.21	88.95	-9.59
Cash at Beginning of Period	169.51	129.79	26.09	105.31	16.35	25.95
Cash at End of Period	799.62	169.51	129.79	26.09	105.31	16.35
Free Cash Flow	-225.81	-117.93	-81.66	-46.28	-33.37	-14.30

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Structure Therapeutics Cash Flow

What is Structure Therapeutics's free cash flow?

Structure Therapeutics had negative free cash flow of $225.81M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$222.20M minus $3.61M of capital expenditures.

How much does Structure Therapeutics spend on capital expenditures?

Structure Therapeutics spent $3.61M on capital expenditures in fiscal 2025, compared with $1.29M a year earlier.

Does Structure Therapeutics pay dividends or buy back shares?

Yes. In fiscal 2025 Structure Therapeutics returned $618.00K in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition